ADAP
Adaptimmune Therapeutics
ADAP
ADAP
Delisted
ADAP was delisted on the 27th of October, 2025.
10 hedge funds and large institutions have $79.7K invested in Adaptimmune Therapeutics in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
99% less capital invested
Capital invested by funds: $5.47M → $79.7K (-$5.39M)
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$2.42M | |
| 2 | -$867K | |
| 3 | -$527K | |
| 4 |
Morgan Stanley
New York
|
-$477K |
| 5 |
Jane Street
New York
|
-$365K |